Zhiwei Liao | Biochemistry | Best Researcher Award

Published on by Academic Achievements

Best Researcher Award

Zhiwei Liao
Huazhong University of Science and Technology, China

Zhiwei Liao
Affiliation Huazhong University of Science and Technology
Country China
Scopus ID 57256472800
Documents 65
Citations 3,364
h-index 31
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Achievements & Awards
ORCID 0000-0002-6723-2522

The Best Researcher Award recognizes researchers whose scholarly work demonstrates research productivity, scientific contribution, and measurable engagement with the academic literature. Zhiwei Liao is presented in this article through the supplied research-profile information, with an institutional affiliation at Huazhong University of Science and Technology in China. The profile identifies Biochemistry, Genetics and Molecular Biology as the relevant subject area and provides Scopus and ORCID identifiers for further reference. These records offer starting points for examining scholarly activity and researcher identity. (1) (2)

Abstract

This article outlines the research profile of Zhiwei Liao in the broad field of Biochemistry, Genetics and Molecular Biology. The supplied Scopus metrics report 65 documents, 3,364 citations, and an h-index of 31. These indicators provide quantitative context for evaluating publication activity and citation visibility, but they do not independently establish the quality, originality, or practical significance of individual studies. The ORCID record provides a persistent researcher identifier that can help distinguish the researcher from others with similar names. (1) (2)

Keywords

  • Best Researcher Award
  • Zhiwei Liao
  • Biochemistry
  • Genetics and molecular biology
  • Research impact
  • Scholarly publications
  • Researcher identifiers

Introduction

Academic recognition programs commonly assess research through a combination of scholarly output, field relevance, research quality, originality, and wider contribution. Bibliographic databases help organize publications and citation information, while persistent identifiers support reliable attribution of research outputs. Scopus and ORCID serve different but complementary purposes: Scopus presents indexed publication and citation information, whereas ORCID provides a persistent identifier and researcher-maintained record. (1) (2)

Research Profile

The supplied profile associates Zhiwei Liao with Huazhong University of Science and Technology, China, and identifies Biochemistry, Genetics and Molecular Biology as the subject area. The provided Scopus author identifier is 57256472800, and the ORCID iD is 0000-0002-6723-2522. The supplied metrics—65 documents, 3,364 citations, and an h-index of 31—should be treated as profile data provided for this article and checked against the live database before publication. (1) (2)

Research Contributions

Biochemistry, genetics, and molecular biology encompass the investigation of biological molecules, genetic processes, cellular mechanisms, and interactions that influence living systems. Research in these fields can contribute to foundational knowledge and may inform biomedical, biotechnology, and life-science applications. A detailed account of Liao’s specific contributions requires examination of verified publications, abstracts, methods, findings, and independent evidence of use or influence. This article therefore does not attribute particular discoveries or clinical outcomes without supporting source material.

Publications

The supplied Scopus profile lists 65 documents. A publication-level assessment should consider article titles, publication venues, authorship, dates, research methods, and the relevance of each work to the stated subject area. Individual publication titles and DOI identifiers have not been supplied in the input data, so specific papers cannot be reliably listed here. The Scopus author profile is the appropriate starting point for checking indexed records and available citation details. (1)

Research Impact

Citation counts provide one indication of how often indexed publications are cited by other works. The h-index combines publication output and citation frequency, but its interpretation varies across disciplines, career stages, database coverage, and authorship practices. The reported values of 3,364 citations and an h-index of 31 can inform an initial assessment, but should be considered alongside research quality, reproducibility, collaboration, and broader scholarly or societal relevance. (3)

Award Suitability

The supplied publication and citation indicators may be relevant to consideration for a Best Researcher Award. A balanced evaluation by the International Academic Achievements & Awards should also examine documented research originality, methodological rigor, publication quality, field-specific influence, ethical research practice, and evidence supporting the nominee’s individual contributions. The metrics alone should not be treated as confirmation of an award decision. Eligibility and recognition should be determined according to the event’s published criteria and review process.

Conclusion

Zhiwei Liao’s supplied profile records research activity in Biochemistry, Genetics and Molecular Biology, with an affiliation at Huazhong University of Science and Technology in China. The reported Scopus metrics offer a quantitative overview of scholarly output and citation visibility. For a reliable academic recognition profile, these indicators should be verified against the current Scopus record and considered together with the researcher’s publications, contributions, and supporting evidence. The linked Scopus and ORCID records provide starting points for further verification.

References

  1. Elsevier. (n.d.). Scopus Author Profile: Zhiwei Liao, Author ID 57256472800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57256472800
  2. ORCID. (n.d.). Zhiwei Liao – ORCID Record. ORCID, researcher identifier 0000-0002-6723-2522.
    https://orcid.org/0000-0002-6723-2522
  3. Zhang, W., Li, G., Luo, R., Lei, J., Song, Y., Wang, B., Ma, L., Liao, Z., Ke, W., Liu, H., et al. (2022). Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis. Experimental and Molecular Medicine.
    DOI: https://doi.org/10.1038/s12276-022-00729-9
  4. Ma, L., Li, G., Lei, J., Song, Y., Feng, X., Tan, L., Luo, R., Liao, Z., Shi, Y., Zhang, W., et al. (2022). Nanotopography Sequentially Mediates Human Mesenchymal Stem Cell-Derived Small Extracellular Vesicles for Enhancing Osteogenesis. ACS Nano.
    DOI: https://doi.org/10.1021/acsnano.1c07150
  5. Ma, L., Ke, W., Liao, Z., Feng, X., Lei, J., Wang, K., Wang, B., Li, G., Luo, R., Shi, Y., et al. (2022). Small extracellular vesicles with nanomorphology memory promote osteogenesis. Bioactive Materials.
    DOI: https://doi.org/10.1016/j.bioactmat.2022.01.008

Corantin Maurin | Biochemistry | Best Researcher Award

Published on by Academic Achievements

Dr. Corantin Maurin | Biochemistry | Best Researcher Award

Dr. Corantin Maurin | Biochemistry | Research Officer at Jean Monnet University | France

Dr. Corantin Maurin is a biomedical researcher specializing in ocular microbiology, tissue engineering, and infectious diseases. His academic and scientific career has been defined by interdisciplinary collaboration and a strong commitment to translational research that bridges clinical application with basic science. Through his work in ophthalmic bioengineering, Dr. Maurin has contributed to pioneering studies in corneal regeneration, virology, and host-pathogen interaction. His research has significantly advanced the scientific understanding of eye infections and tissue modeling, earning him recognition within both national and international academic communities. Driven by innovation and a passion for medical advancement, Dr. Maurin continues to be a respected contributor to high-impact projects and scholarly initiatives.

Academic Profile:

ORCID

Scopus

Education:

Dr. Corantin Maurin earned his Ph.D. in biomedical sciences from a prestigious research university renowned for its excellence in medical and health-related research. His doctoral work focused on corneal biology and the molecular dynamics of ocular infections. The rigorous academic training he received during his postgraduate studies allowed him to develop a solid foundation in cellular and tissue engineering, molecular diagnostics, and microbiological analysis. This academic background has equipped him with the necessary expertise to engage in interdisciplinary research and foster collaborations across various domains of biomedical science.

Experience:

Throughout his career, Dr. Corantin Maurin has held research roles in leading academic laboratories and clinical research institutions. His professional journey includes collaborations with ophthalmologists, microbiologists, and biomedical engineers on a wide range of research initiatives. He has actively contributed to international research consortia and multicenter studies focusing on infectious keratitis, corneal storage techniques, and regenerative therapies. Dr. Maurin has played a key role in designing experimental models for ocular diseases, and his contributions have helped bridge gaps between laboratory discoveries and clinical implementation. He is also involved in training early-career scientists and supporting the development of ethical research practices within his institutions.

Research Interest:

Dr. Corantin Maurin’s research interests lie at the intersection of ocular tissue engineering, infectious disease biology, and regenerative medicine. His ongoing work explores advanced techniques for corneal decellularization, femtosecond laser applications in ophthalmology, and the pathophysiology of viral and bacterial eye infections. He is particularly focused on the development of ex vivo models that replicate human ocular conditions for the purpose of testing novel therapeutic approaches. Additionally, Dr. Maurin is engaged in studies addressing the role of signaling pathways in corneal cell culture and the impact of systemic infections on eye health. His interdisciplinary approach allows him to address complex clinical challenges with innovative scientific solutions.

Award:

Dr. Corantin Maurin has been nominated for this award in recognition of his outstanding contributions to the fields of biomedical science and ocular research. His consistent efforts in publishing peer-reviewed work, participation in international collaborations, and commitment to advancing clinical knowledge through research have made him a prominent figure in his domain. He has received acknowledgment from institutional bodies and research peers for his ability to lead and support transformative projects that improve health outcomes and promote scientific excellence.

Selected Publications:

  • Femtosecond Laser Cutting of Human Crystalline Lens Capsule and Decellularization for Corneal Endothelial Bioengineering (Published: 2024, Citations: 5)

  • Investigating the Role of TGF-β Signaling Pathways in Human Corneal Endothelial Cell Primary Culture (Published: 2023, Citations: 18)

  • Exploration of the Ocular Surface Infection by SARS-CoV-2 and Implications for Corneal Donation: An Ex Vivo Study (Published: 2022, Citations: 42)

  • Key Role of Staphylococcal Fibronectin-Binding Proteins During the Initial Stage of Staphylococcus aureus Keratitis in Humans (Published: 2021, Citations: 29)

Conclusion:

Dr. Corantin Maurin is a dedicated biomedical scientist whose work continues to shape the landscape of ocular research and regenerative medicine. His deep engagement with innovative tissue engineering approaches, infectious disease modeling, and translational science marks him as a leader in his field. With a strong academic foundation, a growing publication record, and proven experience in collaborative research, Dr. Maurin stands out as a highly deserving candidate for this award. His future holds significant promise, not only in advancing scientific knowledge but also in mentoring emerging researchers and contributing to global health solutions through biomedical innovation.